Horizon Pharma Rheumatology LLC
1 clinical trials · Sponsor
◉ Watch Horizon Pharma Rheumatology LLC
| Record | Firm | Date |
|---|---|---|
| Observational Study of the Use of Pegloticase (KRYSTEXXA®) in Refractory Chronic Gout (NCT01466166) | Horizon Pharma Rheumatology LLC | 2011-11-15 |
Track Horizon Pharma Rheumatology LLC automatically
Every clearance here is in the API, with alerts when new ones post.